Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
該当コードがありません。
から:
次の項目別のソート:
日付受信時刻ニュースソース見出しコード企業名
2024/07/0815 : 00GlobeNewswire Inc.LEXIBOOK : RÉSULTATS ANNUELS 2023-24 CONFORMES AUX ATTENTES : CHIFFRE D’AFFAIRES ANNUEL À 58,6M€ (+14,4%). REX ET RN EN CROISSANCE RESPECTIVEMENT À +6,0M€ ET À +5,0M€ GRACE A UNE CONJONCTION EXCEPTIONNELLE DE FACTEURS POSITIFS.EU:ALLEXLexibook Linguistic Electronic System SA
2024/07/0815 : 00GlobeNewswire Inc.Memo Therapeutics AG appoints Paul Carter as Chairperson
2024/07/0815 : 00GlobeNewswire Inc.Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical DevelopmentNYSE:ADCTADC Therapeutics SA
2024/07/0815 : 00Business WireSignum Surgical Granted FDA De Novo Clearance for BioHealx™
2024/07/0815 : 00Business WireEpsilogen announces CTA approval for Phase Ib trial of MOv18 IgE in platinum-resistant ovarian cancer
2024/07/0815 : 00GlobeNewswire Inc.Renforcement en Europe
2024/07/0815 : 00GlobeNewswire Inc.Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical DevelopmentNASDAQ:CGCarlyle Group Inc
2024/07/0815 : 00GlobeNewswire Inc.Volta Finance Limited - Dividend DeclarationLSE:VTAVolta Finance Limited
2024/07/0814 : 56GlobeNewswire Inc.AB Science announces positive results of its Phase 2 study evaluating masitinib in Covid-19LSE:0Q77Ab Science Sa
2024/07/0814 : 56GlobeNewswire Inc.AB Science announces positive results of its Phase 2 study evaluating masitinib in Covid-19EU:ABAb Science
2024/07/0814 : 56GlobeNewswire Inc.AB Science announces positive results of its Phase 2 study evaluating masitinib in Covid-19TG:A8DAb Science
2024/07/0814 : 56GlobeNewswire Inc.AB Science annonce des résultats positifs de son étude de Phase 2 évaluant le masitinib dans la Covid-19EU:ABAb Science
2024/07/0814 : 56GlobeNewswire Inc.AB Science annonce des résultats positifs de son étude de Phase 2 évaluant le masitinib dans la Covid-19LSE:0Q77Ab Science Sa
2024/07/0814 : 56GlobeNewswire Inc.AB Science annonce des résultats positifs de son étude de Phase 2 évaluant le masitinib dans la Covid-19TG:A8DAb Science
2024/07/0814 : 56GlobeNewswire Inc.AB Science announces positive results of its Phase 2 study evaluating masitinib in Covid-19EU:ABAb Science
2024/07/0814 : 46Alliance NewsAlliance NewsLONDON MARKET EARLY CALL: Stocks called up; France political deadlock
2024/07/0814 : 41PR Newswire (US)BioCity announces its endothelin receptor A selective antagonist SC0062 met the primary endpoint in IgA nephropathy in 2-SUCCEED trial: a randomized, double-blind, placebo-controlled Phase 2 trial
2024/07/0814 : 32Alliance NewsAlliance NewsGET READY: Knights Group, ME Group, Unite Group at 0700 BST
2024/07/0814 : 31Alliance NewsAlliance NewsAlliance News UK - start of day
2024/07/0814 : 30GlobeNewswire Inc.BGHL (GBP): NAV(s)EU:BGHSBoussard and Gavaudan Holding
2024/07/0814 : 30GlobeNewswire Inc.BGHL (EUR): NAV(s)LSE:BGHLBoussard & Gavaudan Holding Limited
2024/07/0814 : 30GlobeNewswire Inc.BGHL (EUR): NAV(s)EU:BGHLBoussard And Gavaudan Holding Limited
2024/07/0814 : 30GlobeNewswire Inc.BGHL (GBP): NAV(s)LSE:BGHSBoussard & Gavaudan Holding Limited
2024/07/0814 : 30GlobeNewswire Inc.Sampo plc’s share buybacks 5 July 2024
2024/07/0814 : 28NEWSBTCDogecoin Price Recovery May Stall: Resistance Levels to WatchCOIN:BTCUSDBitcoin
2024/07/0814 : 28NEWSBTCDogecoin Price Recovery May Stall: Resistance Levels to WatchCOIN:DOGEUSDDogecoin
2024/07/0814 : 28NEWSBTCDogecoin Price Recovery May Stall: Resistance Levels to WatchCOIN:ETHUSDEthereum
2024/07/0814 : 27CointelegraphWeekend Wrap: Germany moves $80M more BTC, Vitalik donates 100 ETH and moreCOIN:ETHUSDEthereum
2024/07/0814 : 00GlobeNewswire Inc.Unifiedpost Group announces the strategic decision to enhance the Board composition and the resignation of AS Partners BV, represented by Stefan Yee, from his role as Chairman of the BoardTG:60ZUnifiedpost Group SANV
2024/07/0814 : 00GlobeNewswire Inc.Corbion reports the progress of its € 20 million share buyback program 1 July – 5 July 2024EU:CRBNCorbion N.V.